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Abstract Generation of free radicals is often associated with
the induction and progression of apoptosis. Therefore, antiox-
idants can prove anti-apoptotic, and can help to elucidate specific
apoptotic pathways. Here we studied whether coenzyme Q,
present in membranes in reduced (ubiquinol) or oxidised
(ubiquinone) forms, can affect apoptosis induced by various
stimuli. Exposure of Jurkat cells to K-tocopheryl succinate (K-
TOS), hydrogen peroxide, anti-Fas IgM or TRAIL led to
induction of apoptosis. Cell death due to the chemical agents was
suppressed in cells enriched with the reduced form of coenzyme
Q. However, coenzyme Q did not block cell death induced by the
immunological agents. Ubiquinol-10 inhibited reactive oxygen
species (ROS) generation in cells exposed to K-TOS, and a
mitochondrially targeted coenzyme Q analogue also blocked
apoptosis triggered by K-TOS or hydrogen peroxide. Therefore,
it is plausible that ubiquinol-10 protects cells from chemically-
induced apoptosis by acting as an antioxidant in mitochondria.
Our results also indicate that generation of free radicals may not
be a critical step in induction of apoptosis by immunological
agents. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Apoptosis is a way of cell self-destruction characterised by a
series of tightly controlled steps so that the neighbouring cells
are not exposed to in£ammatory stimuli, and is an inherent
feature of development and disease defence [1,2]. The individ-
ual steps of apoptotic pathways have been elucidated to a
certain extent and many of them are shared in various models
of apoptosis [3].
Of the subcellular organelles, mitochondria are thought to
play a central role in apoptosis triggered by chemical and,
possibly, immunological stimuli, although the precise mecha-
nisms are not known [4]. The general understanding is that,
following exposure of cells to an apoptogenic agent, the mi-
tochondrial outer membrane becomes destabilised. This leads
to the release into the cytoplasm of pro-apoptotic factors in-
cluding cytochrome c (cyt c) [5,6], Smac/Diablo [7] and AIF
[8]. Cyt c forms an apoptosome complex in the cytosol with
pro-caspase-9 and apaf-1 [9], with subsequent cascade-like
activation of the e¡ector caspases [10] and caspase-dependent
nucleases [11].
As mitochondrial destabilisation plays a key role in apopto-
sis, it is important to understand this process and how it can
be modulated. Reactive oxygen species (ROS) are involved in
the early stages of some forms of apoptosis [12], and are
produced by the mitochondrial respiratory chain [13]. Thus,
ROS may be involved in destabilisation of the mitochondrial
[14] and other subcellular membranes [15] with ensuing release
of pro-apoptotic factors, thereby mediating or exacerbating
some forms of cell death [16].
A correlation between ROS production and apoptosis has
been shown, e.g. for cells overexpressing the mitochondrial
anti-apoptotic protein bcl-2, which featured a lower extent
of ROS generation and were more resistant to apoptosis in-
duction [17]. Furthermore, antioxidants such as K-tocopherol
or ascorbate inhibited apoptosis induced by di¡erent stimuli
[18,19], suggesting that pharmacological agents can modulate
apoptosis on the level of ROS generation; however, the role
of mitochondrial ROS in this process is uncertain.
Ubiquinol-10, the reduced form of coenzyme Q10, is a re-
dox-active component of the inner mitochondrial membrane
[20]. Although its role as an antioxidant has been studied
extensively, little is known about its potential to modulate
apoptosis. In vivo, its level can be manipulated by dietary
means, and the ratio of the reduced and oxidised forms of
coenzyme Q is tightly controlled [21,22]. Prompted by the
¢nding that coenzyme Q protects cells exposed to hydrogen
peroxide from DNA strand breaks [23] and the notion that
ROS are likely mediators of apoptosis, we investigated the
e¡ects of coenzyme Q on induction of apoptosis in Jurkat T
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lymphoma cells by a range of pro-apoptotic stimuli. Here we
show that the reduced, but not the oxidised, form of coen-
zyme Q is protective against apoptosis induced by biochemical
but not immunological agents.
2. Materials and methods
2.1. Cell culture and treatment
Jurkat T lymphoma cells were maintained in RPMI-1640 supple-
mented with 10% FCS and antibiotics. The cells were split when
reaching about 1.5U106 per ml, and used for experiments at
0.5U106 per ml. Apoptosis was induced by addition of 50 WM K-to-
copheryl succinate (K-TOS) (Sigma) in DMSO, 100 WM hydrogen
peroxide, 20 ng/ml anti-Fas IgM (Coulter Immunochemicals) or 40
ng/ml human recombinant TNF-related apoptosis-inducing ligand
(hrTRAIL) prepared as follows. The extracellular part of human
TRAIL (amino acids 95^281) obtained by PCR from the HPB T
cell line cDNA library was subcloned into pBSK, sequenced and
further subcloned into the His-tagged reading frame of pET15b.
The protein was expressed in Escherichia coli and puri¢ed using the
TALON (Clontech) and SP-Sepharose columns. In some cases, cells
were enriched with reduced (CoQ10H2) or oxidised coenzyme Q
(CoQ10) (see below) prior to apoptosis induction, or pre-treated
with a mitochondrially targeted coenzyme Q (mito-Q) [24] or methyl-
triphenylphosphonium bromide (TPMP; Aldrich).
2.2. Assessment of apoptotic markers
Phosphatidyl serine (PS) externalisation was assessed using the an-
nexin V-FITC kit (PharMingen) as described elsewhere [25]. Caspase
activity was assessed as described [26], using Ac-DEVD-pNA and Ac-
VEID-pNA, as substrates for caspase-3 and -6, respectively. Activa-
tion of caspase-3 was estimated by incubating cells with an anti-cas-
pase-3 IgG (PharMingen) recognising its activated form, followed by
incubation with secondary antibody, and the £uorescence intensity of
the cells was assessed by £uorescence-assisted cell sorting (FACS;
Becton Dickinson) [25]. Mitochondrial inner membrane potential
(v8m) was estimated using 5,5P,6,6P-tetrachloro-1,1P,3,3P-tetraethyl-
benzimidoazoyl-carbocyanino iodide (JC-1) [27]. Cells were washed,
incubated with 10 WM JC-1 for 15 min at 37‡C, washed with PBS and
analysed by FACS. Formation of ROS was assessed by £ow cytomet-
ric analysis of cells labelled with 2P,7P-dichlorodihydro£uorescein di-
acetate (DCFH-DA; Molecular Probes) as described [28]. Brie£y,
following treatments, cells were incubated for 30 min at 37‡C with
5 WM DCFH-DA, washed, resuspended in PBS and £uorescence in-
tensity assessed by FACS.
2.3. Enrichment of cells with coenzyme Q and its analysis
CoQ10 (a generous gift from Eisai, Japan) at 1 mg/ml in EtOH was
reduced to CoQ10H2 in 3 ml of 10 mM carbonate bu¡er with 25 mM
sucrose (pH 7.4) by addition of 10 mg sodium dithionite. The suspen-
sion was mixed until it appeared white-opalescent, and CoQ10H2 ex-
tracted with three times 2 ml of cyclohexane. The organic phase was
washed with 6 ml of carbonate bu¡er and dried under nitrogen.
Multilamellar liposomes containing CoQ10 or CoQ10H2 were pre-
pared by dissolving 16 mg of dimyristyl-phosphatidylcholine (DMPC;
Sigma) in 1 ml of EtOH containing either form of coenzyme Q (1 mg/
ml) at a coenzyme Q/DMPC molar ratio of 1:20. The solution was
evaporated under a stream of nitrogen. The resulting ¢lm was dis-
persed in 10 ml of degassed PBS by placing the container on a vortex
mixer and sonicated for 20 min. The suspension was centrifuged
(100 000Ug, 1 h) and the supernatant containing small multilamellar
vesicles collected.
Jurkat cells were enriched with CoQ10 or CoQ10H2 by incubation
for 30 min at 37‡C with liposomes containing the respective form of
coenzyme Q (¢nal concentration, 100 WM). After incubation, cells
were washed with PBS and the cellular content of CoQ10 and
CoQ10H2 determined as follows. Cells (3U106) were pelleted and
precipitated with 250 Wl of iso-propanol, stirred for 1 min and centri-
fuged for 3 min at 1000Ug. 100 Wl of the supernatant were subjected
to HPLC using a C8 column (250U4.6 mm C8, 5 Wm particle size;
Supelco) and two C8-ABZ pre-columns (50U4.6 mm, 5 Wm; Supelco).
The mobile phase was prepared by dissolving LiClO4 (10 mM) in
MeOH:iso-propanol:EtOH (72:8:20, v/v/v), and used at a £ow rate
of 0.8 ml/min. Eluting compounds were detected using a Coulochem
electrochemical detector with three serial electrodes set at 30.6, 30.15
and +0.6 V, respectively. Quanti¢cation of the antioxidants was per-
formed by area comparison with the solution of authentic standards
at known concentrations determined spectroscopically. The extinction
coe⁄cients used were O275 = 14 M31 cm31 for CoQ10H2 and O290 = 4.1
M31 cm31 for CoQ10H2.
2.4. Cell fractionation and Western blotting
Jurkat cells were fractionated into mitochondrial and cytosolic frac-
tions as follows. Cells (107) were pelleted (200Ug, 5 min), washed and
resuspended in 500 Wl of bu¡er comprising 250 mM sucrose, 20 mM
HEPES^KOH (pH 7.4), 10 mM KCl, 1.5 mM Na^EGTA, 1.5 mM
Na^EDTA, 1 mM MgCl2, 1 mM DTT and a protease inhibitor cock-
tail (Boehringer Mannheim). After a 30-min incubation on ice, cells
were broken in a glass homogeniser, and the nuclei, unbroken cells
and debris removed by centrifugation (800Ug, 10 min, 4‡C). Super-
natants containing mitochondria were further centrifuged at 22 000Ug
for 15 min at 4‡C. The resulting supernatant representing the cytosolic
fraction was stored at 370‡C until use. The mitochondrial pellet was
lysed by a 20-min incubation at 4‡C in 100 Wl of bu¡er containing 50
mM HEPES (pH 7.4), 1% (v/v) Nonidet P-40, 10% (v/v) glycerol,
1 mM EDTA, 2 mM DTT and the protease inhibitor cocktail. Cel-
lular debris was removed by centrifugation (22 000Ug, 15 min, 4‡C),
and the supernatant containing mitochondrial proteins stored at
370‡C.
For Western blotting, proteins of the cytosolic and mitochondrial
fractions were separated by 15% sodium dodecyl sulphate^polyacryl-
amide gel electrophoresis (SDS^PAGE), and transferred to a nitro-
cellulose membrane. The membrane was blocked overnight at 4‡C in
skim milk and incubated with anti-cytochrome c IgG (Pharmingen)
for 1 h at room temperature followed by a 1-h incubation with per-
oxidase-labelled secondary IgG. Blots were developed using the ECL
kit (Amersham), and exposed to X-Omat AR ¢lm.
3. Results and discussion
As apoptosis induced by various stimuli involves generation
of ROS, increased intracellular levels of redox-active substan-
ces can prove anti-apoptotic. CoQ10H2, the reduced form of
coenzyme Q, exerts a potent antioxidant activity in mem-
branes and lipoproteins, and its level can be enhanced by
supplementation [20^22]. Recently, coenzyme Q has been
shown to suppress DNA strand breaks in lymphocytes chal-
lenged with oxidative stress [23]. Its e¡ect on apoptosis, how-
ever, has not yet been studied in detail. We therefore inves-
Fig. 1. Jurkat cells can be enriched with coenzyme Q. Jurkat cells
were incubated with liposomes containing CoQ10 or CoQ10H2 or
with liposomes only (control), and cell extracts assessed for the two
coenzyme Q forms.
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tigated whether enrichment of Jurkat T lymphoma cells with
CoQ10H2 or CoQ10 can protect them from apoptosis induced
by chemical and immunological apoptogens. Incubation of
cells with CoQ10H2- or CoQ10-enriched liposomes led to an
approximate 5-fold increase in the intracellular level of the
respective redox forms of coenzyme Q10 (Fig. 1).
Exposure of Jurkat cells to both chemical (K-TOS and hy-
drogen peroxide) and immunological inducers of apoptosis
(anti-Fas IgM and hrTRAIL) resulted in typical apoptotic
features, including PS externalisation, caspase-3 and -6 acti-
vation and in a drop in v8m (Fig. 2, Table 1). Although these
markers of apoptosis were observed with all the apoptogens
used, the sequence of events leading to cell death may be
di¡erent for the various stimuli. To investigate the role of
ROS in the induction of apoptosis, we studied the e¡ect of
coenzyme Q supplementation on the process of cell death.
When CoQ10H2-supplemented cells were exposed to K-TOS
and H2O2, apoptosis was suppressed, as documented by
changes of the above apoptotic markers (Fig. 2, Table 1). In
contrast, CoQ10H2 enrichment exerted only a modest e¡ect on
apoptosis induced by the immunological agents anti-Fas IgM
and hrTRAIL (Fig. 2, Table 1).
To clarify the mechanism by which CoQ10H2 may suppress
apoptosis induced by chemical and not by immunological
agents, we studied the e¡ect of coenzyme Q10 supplementation
on cellular production of ROS. As shown in Fig. 3, exposure
of Jurkat cells to K-TOS, anti-Fas IgM and hrTRAIL led to
ROS formation, and this was suppressed in CoQ10H2- but not
CoQ10-enriched cells. These ¢ndings suggest that ROS are
Fig. 2. Reduced coenzyme Q inhibits chemical- but not receptor-in-
duced apoptosis in Jurkat cells. Cells were enriched with the vehicle
(control) or with CoQ10 or CoQ10H2, exposed to K-TOS (50 WM,
12 h), hydrogen peroxide (100 mM, 6 h), anti-Fas IgM (20 ng/ml,
12 h) or rhTRAIL (40 ng/ml, 12 h), and assessed for FACS estima-
tion of PS externalisation (A) and caspase-3 activation (B).
Fig. 3. Formation of ROS in chemical- and receptor-induced apo-
ptosis is inhibited by reduced coenzyme Q. Control or CoQ10H2-en-
riched cells were exposed to K-TOS, anti-Fas IgM or rhTRAIL
(conditions as in legend to Fig. 2), and the level of ROS assessed
by FACS.
Table 1
Ubiquinol-10 protects Jurkat cells from chemical- but not immunological-induced apoptosis
Treatment Caspase-3 (A405) Caspase-6 (A405) v8m, low cells (% of total)
Control 0.03 þ 0.01 0.04 þ 0.012 14.5 þ 2.5
K-TOS ^ 0.13 þ 0.021 0.16 þ 0.035 45.3 þ 6.2
CoQ10 0.11 þ 0.02 0.13 þ 0.034 43.2 þ 5.1
CoQ10H2 0.036 þ 0.01 0.055 þ 0.012 22.1 þ 3.2
H2O2 ^ 0.1 þ 0.029 0.12 þ 0.03 47.9 þ 6.6
CoQ10 0.12 þ 0.032 0.14 þ 0.034 43.3 þ 5.7
CoQ10H2 0.042 þ 0.012 0.052 þ 0.008 25.9 þ 3.4
anti-Fas ^ 0.15 þ 0.034 0.1 þ 0.025 41.2 þ 4.7
CoQ10 0.13 þ 0.04 0.12 þ 0.012 44.5 þ 5.5
CoQ10H2 0.095 þ 0.025 0.08 þ 0.02 38.7 þ 3.3
TRAIL ^ 0.11 þ 0.02 0.09 þ 0.014 38.9 þ 3.9
CoQ10 0.13 þ 0.03 0.11 þ 0.023 39.8 þ 4.5
CoQ10H2 0.1 þ 0.035 0.075 þ 0.017 36.7 þ 3.1
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playing a major role in apoptosis induced by K-TOS rather
than by the two immunological apoptogens, and that the re-
dox function of CoQ10H2 can modulate apoptosis induced by
chemical stimuli. Thus, CoQ10H2 may act as an antioxidant,
blocking the actions of the oxidants implicated in the induc-
tion of apoptosis. This is supported by the ¢nding that pro-
tection from apoptosis was not observed in cells enriched with
CoQ10, con¢rming that the antioxidant potential of ubiquinol-
10 is essential for its anti-apoptotic activity. This notion is
consistent with reports showing coenzyme Q-dependent inhi-
bition of mitochondrial production of ROS, such as the super-
oxide anion radical [29,30].
While mitochondria are central to apoptosis induced by
chemical triggers, the signalling pathways may bypass mito-
chondria in receptor-induced apoptosis. However, in this type
of cell death, mitochondria may amplify the pro-apoptotic
signalling even if they are not involved in the initial recruit-
ment of the initiator caspase to the death domain on the
cognate receptor. To investigate the potential site of the
anti-apoptotic action of CoQ10H2, we used a recently synthe-
sised mitochondrially targeted analogue of coenzyme Q10,
mito-Q [24]. This compound contains at the end of its ali-
phatic side chain a positively charged triphenylphosphonium
group, which transports it to mitochondria, so that the
charged group resides within the mitochondrial matrix while
its quinone function is on the surface of the mitochondrial
inner membrane [31]. Moreover, the oxidised form of mito-
Q is reduced and continuously recycled to its active antioxi-
dant form by the mitochondrial respiratory chain [24]. Con-
sistent with the e¡ect of CoQ10H2 on apoptosis, we found that
mito-Q-enriched cells were protected from chemically-, but
not immunologically-, induced apoptosis at the level of PS
externalisation and cytochrome c re-localisation (Fig. 4).
TPMP itself exerted no e¡ect (data not shown). This ¢nding
suggests mitochondria as the site of the anti-apoptotic action
of CoQ10H2.
On the basis of these results, we suggest that ubiquinol-10,
but not ubiquinone-10, inhibits apoptosis induced by chemical
apoptogens, which largely use the distal, mitochondrial signal-
ling pathways. On the other hand, apoptosis triggered by
immunological agents, such as anti-Fas IgM or TRAIL,
which rely on their cognate receptors in apoptosis induction,
appears largely independent of the coenzyme Q status of the
cell (Fig. 5). This further supports the idea of ROS participa-
tion in apoptosis induction and progression, and is consistent
with di¡erences in the pro-apoptotic signalling pathways used
by chemical and immunological agents. Our data thus link the
antioxidant capacity of redox-active compounds like coen-
zyme Q and its analogues [32^35] to their anti-apoptotic po-
tential. That our ¢ndings may be of (patho)physiological rele-
vance is also supported by reports showing disruption of the
redox state of antioxidants including coenzyme Q in patho-
logical situations [36].
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